In addition, PKCβ regulates Akt by modulating the expression of protein tyrosine phosphatase non-receptor type 22 (PTPN22), a phosphatase that is responsible for positively regulating Akt activity, which is overexpressed in CLL cells [41]. The gene discussed is PRKCB; the disease is B-cell chronic lymphocytic leukemia.